Zabofloxacin

DRUG2 trials

Sponsors

IASO Pharma Inc., Dong Wha Pharmaceutical Co. Ltd.

Conditions

Chronic Obstructive Pulmonary DiseaseCommunity Acquired Pneumonia

Phase 2

Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia

TerminatedNCT01081964

IASO Pharma Inc.Community Acquired Pneumonia

Start: 2010-03-31End: 2012-06-30Updated: 2012-05-07

Phase 3

A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg

CompletedNCT01658020

Dong Wha Pharmaceutical Co. Ltd.Chronic Obstructive Pulmonary Disease

Start: 2012-08-31End: 2014-08-31Updated: 2014-10-13

Related Papers

Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations

Journal of Korean Medical Science2020-01-014 citations